{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:31:22Z","timestamp":1794324682467,"version":"4.9.0"},"reference-count":52,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.1080\/14656566.2024.2358131","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T16:32:56Z","timestamp":1718296376000},"page":"783-789","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Elinzanetant, a new combined neurokinin-1\/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms"],"prefix":"10.1080","volume":"25","author":[{"given":"Marlene","family":"Hager","sequence":"first","affiliation":[{"name":"Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Fitz","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of OB\/GYN, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ott","sequence":"additional","affiliation":[{"name":"Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2015.05.001"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2008.12.006"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262900"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0b013e31827d38a5"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2007.09.006"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.4103\/jmh.JMH_7_19"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31818d414e"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.8063"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.3244"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000516"},{"issue":"7","key":"e_1_3_4_13_1","first-page":"979","article-title":"Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women","volume":"31","author":"Kravitz HM","year":"2008","unstructured":"Kravitz HM, Zhao X, Bromberger JT, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31(7):979\u2013990.","journal-title":"Sleep"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1714787"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31709-X"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub5"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77534-9"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2022.09.006"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2022.06.008"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001500"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14097"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30823-1"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000473893"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajhb.1077"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2017.1306507"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/317521"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0913358107"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.462193"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-1-152"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02797"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.285"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0005"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107960"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12025"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-128-5-2239"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0553"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2013.07.003"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep08466"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609015169"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30823-1"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00677"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001510"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00085-5"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad058"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2305122"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113480990"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.3208"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113517953"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12004"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab108"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002138"},{"key":"e_1_3_4_52_1","volume-title":"FDA approves novel drug to treat moderate to severe hot flashes caused by menopause [internet]. silver spring","unstructured":"FDA approves novel drug to treat moderate to severe hot flashes caused by menopause [internet]. silver spring. (MD (USA)): Food and Drug Administration; [updated 2023 May 12 [cited 2023 May 12]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-novel-drug-treat-moderate-severe-hot-flashes-caused-menopause#:~:text=The%20prescribing%20information%20for%20Veozah%20includes%20a%20warning,the%20first%20nine%20months%20of%20using%20the%20medication"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036592"},{"key":"e_1_3_4_54_1","volume-title":"Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer\u2019s elinzanetant [Internet]","unstructured":"Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer\u2019s elinzanetant [Internet]. Leverkusen (Germany): Bayer Global; [Updated 2023 Mar 19 [cited 2023 Mar 19]. Available from: https:\/\/www.bayer.com\/media\/en-us\/positive-topline-results-from-phase-iii-long-term-study-oasis-3-support-submissions-for-marketing-authorization-for-bayers-elinzanetant"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2024.2358131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T06:02:36Z","timestamp":1727244156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2024.2358131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,5,2]]}},"alternative-id":["10.1080\/14656566.2024.2358131"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2024.2358131","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}